06955 博安生物
公司資料 - 財務比率
山東博安生物技術股份有限公司 股票編號: 06955
SHANDONG BOAN BIOTECHNOLOGY CO., LTD. 集團網址: http://www.boan-bio.com
盈利能力分析
2025/12 2024/12 2023/12 2022/12 2021/12
資產回報率 (%)0.205%2.829%-5.275%-15.397%-14.955%
股東資金回報率 (%)0.326%4.939%-8.719%-22.340%-22.173%
資本運用回報率 (%)0.219%3.323%-7.148%-19.166%-12.210%
 
邊際利潤分析
毛利率 (%)71.664%74.713%66.162%68.655%67.115%
未計利息、稅項、折舊及攤銷前利潤率 (%)16.453%24.554%-3.831%-48.662%-108.951%
稅前邊際利潤率 (%)0.910%10.077%-19.313%-64.297%-142.036%
純利率 (%)0.910%10.077%-19.313%-64.297%-142.036%
 
變現能力分析
流動比率 (X)2.328 X1.474 X1.091 X1.795 X3.608 X
速動比率 (X)2.178 X1.215 X0.838 X1.491 X3.229 X
 
財務槓桿分析
總負債 / 總資產比率 (%)33.589%42.341%43.192%35.603%26.342%
總負債 / 股東資金比率 (%)50.577%73.432%76.032%55.287%35.762%
非流動負債 / 股東資金比率 (%)19.019%33.975%26.531%22.033%18.975%
利息盈利率 (倍)1.185 X3.242 XN/AN/AN/A
 
營運效率分析
存貨周轉率日數 (日)69.346 Day(s)83.808 Day(s)91.209 Day(s)85.765 Day(s)136.282 Day(s)
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.